CNN: Moderna's clinical trial numbers show there's 'no way' Trump can have a vaccine by Election Day
UC expert leading local trial is encouraged by community response
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, is featured in an article by CNN on the trial of the Moderna vaccine for COVID-19. In the story, Peter Hotez, MD, a vaccinologist at Baylor College of Medicine and CNN medical expert, says there is "no way" the vaccine will be ready by Election Day Nov. 3 as President Trump is hoping.
Fichtenbaum, who is the medical director for the Moderna trial at UC, told CNN he expects to start enrolling patients at his site in the middle of August. He said his goal is to enroll 500 patients, and already 2,500 patients have reached out to him inquiring about the trial.
"We're getting good numbers," he said of the trial. "I think this accrual is going to hit its target pretty quickly."
Read the entire story here.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Local 12: Head injury survivor, doctor share importance of...
April 23, 2024
Local 12 spoke with patient Shane Shapiro and the University of Cincinnati's Laura Ngwenya about the importance of wearing a helmet following Shapiro's traumatic brain injury and recovery.
WVXU: Why is part of Green Township called Dent?
April 23, 2024
UC College of Arts and Sciences professor tells WVXU that Ohio's glacial past might explain how Dent got its name.
WVXU: Find your CPAP annoying? UC researchers are working on a...
April 22, 2024
Dr. Liran Oren is leading a research team at the University of Cincinnati developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.